Merdod Ghafouri, DO
Cardiovascular Disease · Annandale, VANPI 1811925928
Payments from drug & device makers
What this record shows
This record is dominated by other: $69,500 of the $78,514 with a category attached, or 88.5%. Angiodynamics, Inc. accounts for 88.5% of it on its own, with 36 other manufacturers making up the rest. Reporting peaked in 2023 at $31,282 and has fallen 95.7% since, to $1,351 in 2025. Among cardiovascular disease clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 205 payments — averaging $383.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$70K
- Abbott$1K
- Novartis$731
- E.r. Squibb & Sons, L.L.C.$664
- Pfizer$559
- Novo Nordisk$520
- plus $5K from 31 others
Across 8 payments — averaging $5202.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$22K
- Novartis$20K
What the payments were for
- Food & beverage$8,99811%
- Education$170%
- Other$69,50089%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 3 | $69,500 |
| Abbott | 15 | $1,274 |
| Novartis | 25 | $731 |
| E.r. Squibb & Sons, L.L.C. | 9 | $664 |
| Pfizer | 20 | $559 |
| Novo Nordisk | 6 | $520 |
| Amgen | 19 | $448 |
| Cvrx, Inc. | 6 | $439 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $372 |
| Johnson & Johnson(2 entities) | 12 | $332 |
| Medtronic(2 entities) | 5 | $320 |
| Esperion Therapeutics, Inc. | 7 | $294 |
| Sanofi-aventis U.S. LLC | 10 | $285 |
| Scpharmaceuticals Inc. | 3 | $260 |
| Cardiovascular Systems Inc. | 2 | $239 |
| Merck | 13 | $238 |
| Edwards Lifesciences | 2 | $187 |
| Boston Scientific | 5 | $179 |
| Amarin Pharma, Inc. | 4 | $156 |
| Atricure, Inc. | 2 | $150 |
| Bridgebio Pharma, Inc. | 1 | $144 |
| ZOLL Respicardia, Inc. | 1 | $136 |
| Lilly USA, LLC | 1 | $125 |
| Abiomed | 1 | $124 |
| Ionis Pharmaceuticals, Inc. | 1 | $122 |
| Boehringer Ingelheim | 2 | $122 |
| AstraZeneca | 6 | $112 |
| Kestra Medical Technology Services, Inc. | 1 | $101 |
| Siemens Medical Solutions USA, Inc. | 1 | $93 |
| Philips North America LLC | 3 | $89 |
| Actelion Pharmaceuticals US, Inc. | 1 | $66 |
| Medicomp Inc | 1 | $29 |
| Recor Medical Inc | 1 | $28 |
| Livanova USA, Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 2 | $24 |
| Cardiofocus, Inc. | 1 | $18 |
| Altathera Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$69,500
- CAMZYOS$491
- Barostim Neo System$280
- Mitra Clip system$270
- ENTRESTO$245
- FUROSCIX$244
- NEXLETOL$233
- LEQVIO$230
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$170
- CardioMEMS HF System$147
- Attruby$144
- Diamondback Peripheral$141
- remede System$136
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$134
- ENSITE$129
- AVEIR$126
- Vascepa$125
- Repatha$125
- Claria MRI$125
- NEXLIZET$125
How this compares
$78,514 in reported general payments places this provider in the 95th percentile of 548 cardiovascular disease providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 117 | $142,776 |
| XareltoRivaroxaban | 64 | $81,859 |
| EntrestoSacubitril/Valsartan | 42 | $59,118 |
| Repatha SureclickEvolocumab | 48 | $58,649 |
| Praluent PenAlirocumab | 17 | $19,303 |
| Metoprolol Succinate | 239 | $3,367 |
| Atorvastatin Calcium | 174 | $2,231 |
| Rosuvastatin Calcium | 100 | $1,751 |
| Losartan Potassium | 114 | $1,694 |
| Carvedilol | 155 | $1,560 |
| Valsartan | 31 | $1,278 |
| Amiodarone Hcl | 14 | $1,152 |
| Amlodipine Besylate | 113 | $936 |
| Ezetimibe | 27 | $779 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 22 | $725 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $559 | $142,776117 claims |
| Johnson & JohnsonXarelto | $332 | $81,85964 claims |
| NovartisEntresto | $731 | $59,11842 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 548 cardiovascular disease providers in Virginia.
Other cardiovascular disease in Annandale
- George VetrovecRichmond$2.3M
- Hamid TaheriManassas$501K
- Cyrus HadadiNorfolk$360K
- Michael AyersCharlottesville$305K
- David LimCharlottesville$264K
- Alexander TruesdellFalls Church$167K
- Antonio AbbateCharlottesville$161K
- Christopher OconnorFalls Church$161K
- Roberta ChapmanGloucester$155K
- Shaival KapadiaColonial Heights$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.